Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything

• Main Authors: Conway Jessica M, Tuite Ashleigh R, Fisman David N, Hupert Nathaniel, Meza Rafael, Davoudi Bahman, English Krista, van den Driessche P, Brauer Fred, Ma Junling, Meyers Lauren Ancel, Smieja Marek, Greer Amy, Skowronski Danuta M, Buckeridge David L, Kwong Jeffrey C, Wu Jianhong, Moghadas Seyed M, Coombs Daniel, Brunham Robert C, Pourbohloul Babak
• Format: Article
• Language: English
• Published: BMC 2011-12-01
• Series: BMC Public Health
• Online Access: http://www.biomedcentral.com/1471-2458/11/932

<p>Abstract</p> <p>Background</p> <p>Much remains unknown about the effect of timing and prioritization of vaccination against pandemic (pH1N1) 2009 virus on health outcomes. We adapted a city-level contact network model to study different campaigns on influenza morbidity and mortality.</p> <p>Methods</p> <p>We modeled different distribution strategies initiated between July and November 2009 using a compartmental epidemic model that includes age structure and transmission network dynamics. The model represents the Greater Vancouver Regional District, a major North American city and surrounding suburbs with a population of 2 million, and is parameterized using data from the British Columbia Ministry of Health, published studies, and expert opinion. Outcomes are expressed as the number of infections and deaths averted due to vaccination.</p> <p>Results</p> <p>The model output was consistent with provincial surveillance data. Assuming a basic reproduction number = 1.4, an 8-week vaccination campaign initiated 2 weeks before the epidemic onset reduced morbidity and mortality by 79-91% and 80-87%, respectively, compared to no vaccination. Prioritizing children and parents for vaccination may have reduced transmission compared to actual practice, but the mortality benefit of this strategy appears highly sensitive to campaign timing. Modeling the actual late October start date resulted in modest reductions in morbidity and mortality (13-25% and 16-20%, respectively) with little variation by prioritization scheme.</p> <p>Conclusion</p> <p>Delays in vaccine production due to technological or logistical barriers may reduce potential benefits of vaccination for pandemic influenza, and these temporal effects can outweigh any additional theoretical benefits from population targeting. Careful modeling may provide decision makers with estimates of these effects before the epidemic peak to guide production goals and inform policy. Integration of real-time surveillance data with mathematical models holds the promise of enabling public health planners to optimize the community benefits from proposed interventions before the pandemic peak.</p>